Supplementary Figure 5. (a) KAT6B especifically acetylates lysine 23 of histone H3 in vitro....

1
Supplementary Figure 5. (a) KAT6B especifically acetylates lysine 23 of histone H3 in vitro. Recombinant GST-Flag-tagged KAT6B HAT domains (wild type, and K815L mutant) were assayed for the presence of histone acetyltransferase activity (left-top). Core histones used as substrates were stained with Comassie blue (left-midle). Flag-tagged wild-type and catalytically inactive HAT domains were analyzed in western blot (left-bottom). Recombinant GST-Flag-tagged KAT6B HAT were assayed in western blot for the presence of specific histone H3K23 acetyltransferase activity (right-top). Histone H3 from core histones used as substrates was analyzed in western blot (righ-middle). Flag-tag HAT domains were analyzed in western blot (right-bottom). (b) Recombinant GST- Flag-tagged KAT6B HAT domains were assayed for the presence of histone acetyltransferase activity on recombinant histone H3 (top). Recombinant histone H3 was stained with Comassie blue (midle) and GST-Flag-tagged KAT6B HAT domains were analyzed in western blots (bottom). (c) The expression of HDAC1, 2, 3 and 6 was diminished using specific shRNAs targeting each protein in NCI-N417 cells. Western blot analysis of each HDAC and the acetylation of H3K23 revealed that HDAC1 is involved in H3K23 deacetylation. (d) Quantitative reverse-transcription PCR results confirmed the microarray expression data: twenty one genes (in addition to the four genes shown in Fig. 3f) presented significantly less expression in KAT6B shRNA-depleted cells than in scramble cells. Significance of permutation tests: *, p <0.05; **, p < 0.01; ***, p <0.001. a b H3K23ac Anti-Flag KAT6B-HAT Total H3 KAT6B- HAT-K815L Coomassie blue [acetyl-1- 14 C]- coenzyme A Anti-Flag KAT6B-HAT KAT6B- HA T -K815L Coomassie blue KAT6B-HAT KAT6B- HA T - K815L [acetyl-1- 14 C]- coenzyme A Anti-Flag NCI-N417 shRNA_3 H3K23ac Lamin B1 HDAC3 NCI-N417 S c ramble N CI - N 4 17 shRN A_2a NCI-N417 s h RNA_2b H3K23ac Lamin B1 HDAC2 NC I-N417 Scramble H3K23ac Lamin B1 HDAC6 N CI-N417 shRNA_6 NCI-N417 S c ramble NCI-N417 shRNA_1a NCI-N417 shRN A_1b H3K23ac Lamin B1 HDAC1 NCI-N417 S c ramble c d 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA PIAS4 * 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA JHDM1D ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA BNIP3L ** 0.2 0.4 0.6 0.0 1.0 1.2 1.4 0.8 N417 Scramble N417 shRNA ADAMTS15 ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA ITPRIP ** CPS1 0.2 0.4 0.6 0.0 1.0 1.2 1.4 0.8 N417 Scramble N417 shRNA ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA CNIH3 *** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA CDKL4 ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA PPAPDC3 ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA ICK ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA CACNA1B ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA CMA1 *** 0.2 0.4 0.6 0.0 1.0 1.2 1.4 0.8 N417 Scramble N417 shRNA MIAT * 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA MRPS10 ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA YRDC ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA SLC38A10 ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA PVRL2 *** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA SEC61A2 ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA ARL8A ** 0.2 0.4 0.6 0.0 1.0 1.2 0.8 N417 Scramble N417 shRNA GNAS-AS1 *** ADAMTS4 0.2 0.4 0.6 0.0 1.0 1.4 1.6 0.8 1.2 N417 Scramble N417 shRNA ** Relative expression Relative expression Relative expression Relative expression Relative expression

Transcript of Supplementary Figure 5. (a) KAT6B especifically acetylates lysine 23 of histone H3 in vitro....

Page 1: Supplementary Figure 5. (a) KAT6B especifically acetylates lysine 23 of histone H3 in vitro. Recombinant GST-Flag-tagged KAT6B HAT domains (wild type,

Supplementary Figure 5. (a) KAT6B especifically acetylates lysine 23 of histone H3 in vitro. Recombinant GST-Flag-tagged KAT6B HAT domains (wild type, and K815L mutant) were assayed for the presence of histone acetyltransferase activity (left-top). Core histones used as substrates were stained with Comassie blue (left-midle). Flag-tagged wild-type and catalytically inactive HAT domains were analyzed in western blot (left-bottom). Recombinant GST-Flag-tagged KAT6B HAT were assayed in western blot for the presence of specific histone H3K23 acetyltransferase activity (right-top). Histone H3 from core histones used as substrates was analyzed in western blot (righ-middle). Flag-tag HAT domains were analyzed in western blot (right-bottom). (b) Recombinant GST-Flag-tagged KAT6B HAT domains were assayed for the presence of histone acetyltransferase activity on recombinant histone H3 (top). Recombinant histone H3 was stained with Comassie blue (midle) and GST-Flag-tagged KAT6B HAT domains were analyzed in western blots (bottom). (c) The expression of HDAC1, 2, 3 and 6 was diminished using specific shRNAs targeting each protein in NCI-N417 cells. Western blot analysis of each HDAC and the acetylation of H3K23 revealed that HDAC1 is involved in H3K23 deacetylation. (d) Quantitative reverse-transcription PCR results confirmed the microarray expression data: twenty one genes (in addition to the four genes shown in Fig. 3f) presented significantly less expression in KAT6B shRNA-depleted cells than in scramble cells. Significance of permutation tests: *, p <0.05; **, p < 0.01; ***, p <0.001.

a b

H3K23ac

Anti-Flag

KAT

6B-H

AT

Total H3

KAT

6B- H

AT-

K81

5LCoomassie

blue

[acetyl-1-14C]-coenzyme A

Anti-Flag

KAT

6B-H

AT

KAT

6B- H

AT-

K81

5L

Coomassie blue

KAT

6B-H

AT

KAT

6B- H

AT-

K81

5L

[acetyl-1-14C]-coenzyme A

Anti-Flag

NC

I-N41

7 sh

RN

A_3

H3K23ac

Lamin B1

HDAC3

NC

I-N41

7 S

cram

ble

NC

I-N41

7 sh

RN

A_2

a

NC

I-N41

7 sh

RN

A_2

b

H3K23ac

Lamin B1

HDAC2

NC

I-N41

7 S

cram

ble

H3K23ac

Lamin B1

HDAC6N

CI-N

417

shR

NA

_6

NC

I-N41

7 S

cram

ble

NC

I-N41

7 sh

RN

A_1

a

NC

I-N41

7 sh

RN

A_1

b

H3K23ac

Lamin B1

HDAC1

NC

I-N41

7 S

cram

blec

d

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

PIAS4

*

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

JHDM1D

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

BNIP3L

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

1.4

0.8

N417 Scramble

N417 shRNA

ADAMTS15

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

ITPRIP

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

N417 Scamble

N417 shRNA

CPS1

0.2

0.4

0.6

0.0

1.0

1.2

1.4

0.8

N417 Scramble

N417 shRNA

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

CNIH3***

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

CDKL4**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

PPAPDC3

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

ICK**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

CACNA1B

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

CMA1

***

0,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

1.4

0.8

N417 Scramble

N417 shRNA

MIAT

*

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

MRPS10

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

YRDC

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

SLC38A10

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

PVRL2***

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

SEC61A2**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

ARL8A

**

0,0

0,2

0,4

0,6

0,8

1,0

1,2

N417 Scamble

N417 shRNA

0.2

0.4

0.6

0.0

1.0

1.2

0.8

N417 Scramble

N417 shRNA

GNAS-AS1***

0,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

N417 Scamble

N417 shRNA

ADAMTS4

0.20.40.6

0.0

1.0

1.41.6

0.8

1.2

N417 Scramble

N417 shRNA

**

Rel

ativ

e ex

pres

sion

Rel

ativ

e ex

pres

sion

Rel

ativ

e ex

pres

sion

Rel

ativ

e ex

pres

sion

Rel

ativ

e ex

pres

sion